#USA #Atlanta #Hidradenitis Suppurativa #Educational Support #UCB Scholarship

UCB Introduces an Innovative Scholarship for Hidradenitis Suppurativa Patients

UCB, a leading biopharmaceutical company, has unveiled the inaugural UCB Hidradenitis Suppurativa Scholarship™ Program, a groundbreaking initiative aimed at empowering adults affected by Hidradenitis Suppurativa (HS) to further their education and career aspirations. This program, officially launched on June 1, 2026, is designed to alleviate financial burdens for individuals over 18 years with HS and their immediate family members.

The application process opened on the same day and will remain available until September 1, 2026. UCB plans to award up to 11 scholarships in this first round, thereby providing critical support to a community often faced with daunting challenges. Rhonda Peebles, UCB's Head of U.S. Dermatology, emphasized the resilience and determination of individuals living with HS, stating, "This community is made up of people who are resilient, inspired, and incredibly driven. Our scholarship program is a way to invest in their goals and access to opportunities that may have seemed out of reach due to their health challenges."

Living with Hidradenitis Suppurativa can lead to immense physical discomfort and emotional distress, including feelings of embarrassment or psychological isolation. These symptoms can profoundly interfere with work and educational pursuits. PreShus Lee, a scholarship advocate and HS patient, shared her personal experience, highlighting how her diagnosis initially served as an obstacle but ultimately motivated her to succeed educationally. “Finishing my education became more than just a milestone; it was a way of reclaiming my narrative,” she explained. “This scholarship can help lift some of the weight that comes with navigating HS daily and remind us that our stories matter.”

The UCB Hidradenitis Suppurativa Scholarship™ Program aims to facilitate financial assistance for a range of educational opportunities. This includes funding for undergraduate or graduate degrees, certification courses, vocational training, and various career development paths. UCB's commitment is evident through its existing initiatives aimed at the HS community, such as events like the HS Summit and programs like the HS Advocate Community.

In addition to the HS Scholarship, UCB has a broader mandate to support patient communities affected by serious diseases, including those living with myasthenia gravis and epilepsy. The company actively seeks to expand its scholarship offerings to provide additional resources for these groups.

For those interested in applying, detailed information including eligibility criteria and application guidelines can be found at www.ucbhsscholarship.com.

Understanding Hidradenitis Suppurativa

Hidradenitis suppurativa is a chronic inflammatory skin condition characterized by painful nodules and abscesses, which can severely impact one’s quality of life. Often manifesting in areas such as the armpits, groin, and buttocks, individuals with HS experience unpredictable flare-ups that can lead to persistent pain and emotional challenges.

The condition typically surfaces in early adulthood and affects approximately 1% of the population across many regions. With the launch of the UCB Hidradenitis Suppurativa Scholarship™ Program, UCB is not just offering financial assistance but is also advocating for visibility and support for the HS community, a testament to its commitment to transforming broader healthcare narratives for individuals living with complex diseases.

Conclusion

This new scholarship program represents a significant step forward in supporting the educational and professional development of individuals with Hidradenitis Suppurativa and their families. UCB’s dedication to this initiative shows promise in addressing the multifaceted needs of this community, fostering hope and resilience where it is most needed.